Bengaluru: Biocon executive chairperson Kiran Mazumdar Shaw has tested positive for COVID-19.
Shaw informed this in a tweet on Monday night.
Biocon was recently in the news for making the controversial drug Itolizumab.
In July, Shaw claimed that Itolizumab had been approved in India and since the country was in a medical emergency, it was decided to go ahead with a clinical trial involving a cohort of 30 patients.’
She had further said the regulatory process was extremely robust and the scientific discussions on the trial were of a very high order.
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
Delhi/Mumbai: Twin tragedies in Delhi and Mumbai claimed the lives of a pair of 18-month-old… Read More
Jajpur: A total of 894 ineligible people fraudulently received benefits under an old-age pension scheme… Read More
Bhubaneswar: The International Conference on Recent Advances in Nanomedicine brought together more than 500 participants,… Read More
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
Bhopal: Prime Minister Narendra Modi lashed out at critics of the Mahakumbh Mela at a… Read More
This website uses cookies.
